Biosimilar Newsletter Archive

1. 05.20.22 -- Enhancing The Patient Experience During Subcutaneous Biologic Delivery 5/20/2022

   05/20/22 Biosimilar Development Newsletter

2. 05.19.22 -- Post-COVID Supply Chain Strategies For BioPharma 5/19/2022
   05/19/22 Biosimilar Development Newsletter
3. 05.15.22 -- Celltrion's Remsima Wins Brazilian Tender 5/15/2022
   05/15/22 Biosimilar Development Newsletter
4. 05.12.22 -- Celltrion's Remsima Wins Brazilian Tender 5/12/2022
   05/12/22 Biosimilar Development Newsletter
5. 05.06.22 -- mRNA Manufacturing Strategies 5/6/2022

   05/06/22 Biosimilar Development Newsletter

6. 05.05.22 -- CMC & Quality Considerations When Engaging Your CDMO 5/5/2022
   05/05/22 Biosimilar Development Newsletter
7. 05.03.22 -- New Episodes: Allogeneic CAR-T Therapies, Antibodies for Severe Allergies, and more. 5/3/2022
   05/03/22 Biosimilar Development Newsletter
8. 04.28.22 -- Amgen's Ph3 Biosimilar Stelara Trial Boasts Positive Results 4/28/2022
   04/28/22 Biosimilar Development Newsletter
9. 04.21.22 -- Amneal Achieves Second U.S. Biosimilar Approval 4/21/2022
   04/21/22 Biosimilar Development Newsletter
10. 04.14.22 -- BioPharma Deal-Making In 2022: Key Trends 4/14/2022
    04/14/22 Biosimilar Development Newsletter